1,971 top medical experts on Brain Neoplasms across 55 countries and 41 U.S. states, including 1,885 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Brain Diseases (4,643), Central Nervous System Neoplasms (3,993) and Narrower Categories: Cerebral Ventricle Neoplasms (2,348), Infratentorial Neoplasms (2,413), Neurocytoma (1,119), Pinealoma (1,913), Supratentorial Neoplasms (2,778).
  4. Clinical Trials ClinicalTrials.gov : at least 1,392 including 106 Active, 507 Completed, 325 Recruiting
  5. Synonyms: Brain Cancer,  Brain Metastases,  Brain Tumors,  Cancer of Brain,  Malignant Primary Brain Tumors,  Intracranial Neoplasms


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Wick, Wolfgang     Google Publications
    Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Subjects: Glioblastoma; Glioma; Astrocytoma; Isocitrate Dehydrogenase; Magnetic Resonance Imaging
    Categories: Genetics; Drug Therapy; Pathology; Therapeutic Use; Therapy; Methods
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. (2021)

  2. Wen, Patrick Yung   Neurology   ClinicalTrials.gov Google Publications
    Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: . Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Medical school: Other (MD, 1981)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 66/100
    Disclosed payments in 2021 from 19 biomedical companies, totalling $38,169.34, including $13,238.84 from  Servier Pharmaceuticals LLC
    Subjects: Glioblastoma; Glioma; Antineoplastic Agents; Neoplasm Recurrence, Local; Angiogenesis Inhibitors
    Categories: Drug Therapy; Therapeutic Use; Therapy; Genetics; Methods; Pathology
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. (2019)

  3. Mehta, Minesh P   Radiation Oncology   ClinicalTrials.gov Google Publications
    Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Office 1R203, Miami, FL, 33176, USA.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Medical school: Other (MD, 1981)
    Medicare Accepted
    Disclosed payments in 2021 from 5 biomedical companies, totalling $7,069.84, including $5,000 from  Mevion_Medical_Systems_Inc
    Subjects: Glioblastoma; Glioma; Dacarbazine; Radiosurgery; Cranial Irradiation
    Categories: Therapy; Drug Therapy; Therapeutic Use; Radiotherapy; Secondary; Mortality
    A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014)
    Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (2020)

  4. Cloughesy, Timothy F   Neurology   ClinicalTrials.gov Google Publications
    Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, 90095, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Medical school: Tulane University School of Medicine (MD, 1987)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 66/100
    Disclosed payments in 2021 from 9 biomedical companies, totalling $25,173.74, including $12,438.74 from  Servier Pharmaceuticals LLC
    Subjects: Glioblastoma; Glioma; Neoplasm Recurrence, Local; Magnetic Resonance Imaging; Angiogenesis Inhibitors
    Categories: Drug Therapy; Therapeutic Use; Genetics; Metabolism; Therapy; Pathology
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. (2014)

  5. Stupp, Roger   Hematology & Oncology   Google Publications
    Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Department of Neurological Surgery and Department of Neurology, Northwestern Medicine and Northwestern University, Chicago, IL, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $920,372 over the last 5 years
    Disclosed payments in 2021 from 5 biomedical companies, totalling $15,357.77, including $10,200 from  GT Medical Technologies, Inc
    Subjects: Glioblastoma; Glioma; Dacarbazine; Antineoplastic Agents; Antineoplastic Agents, Alkylating
    Categories: Drug Therapy; Therapy; Genetics; Therapeutic Use; Diagnosis; Methods
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. (2017)

  6. Reardon, David A   Anatomic Pathology & Clinical Pathology   ClinicalTrials.gov Google Publications
    Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $5,857,417 over the last 5 years
    Subjects: Glioblastoma; Glioma; Neoplasm Recurrence, Local; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents
    Categories: Drug Therapy; Therapeutic Use; Therapy; Genetics; Methods; Diagnosis
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. (2020)

  7. Brown, Paul D   Radiation Oncology   Google Publications
    Mayo Clinic Cancer Center, Rochester, MN. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Medical school: University of North Dakota School of Medicine (MD, 1995)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 79.7/100
    Subjects: Radiosurgery; Glioblastoma; Glioma; Cranial Irradiation; Melanoma
    Categories: Radiotherapy; Therapy; Mortality; Secondary; Drug Therapy; Methods
    A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014)
    Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. (2016)

  8. Gilbert, Mark R   Otolaryngology   ClinicalTrials.gov Google Publications
    Neuro-Oncology Branch, NCI, NIH, Bethesda, Maryland.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $4,545,024 over the last 5 years
    Disclosed payments in 2021 from 5 biomedical companies, totalling $286.2, including $117.44 from  Davol Inc.
    Subjects: Glioblastoma; Glioma; Neoplasm Recurrence, Local; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols
    Categories: Drug Therapy; Therapeutic Use; Genetics; Therapy; Diagnosis; Pathology
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014)

  9. Vogelbaum, Michael A   Neurological Surgery   ClinicalTrials.gov Google Publications
    Moffit Cancer Center, Tampa, FL.
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Medical school: University of Virginia School of Medicine (MD, 1985)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 81/100
    Disclosed payments from biomedical company (Elekta, Inc.) in 2021 for $161.83
    Subjects: Glioblastoma; Glioma; Radiosurgery; Antineoplastic Agents; Neoplasm Recurrence, Local
    Categories: Therapy; Surgery; Methods; Pathology; Drug Therapy; Secondary
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014)

  10. Berger, Mitchel S   Neurological Surgery   ClinicalTrials.gov Google Publications
    Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $9,496,129 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 62/100
    Subjects: Glioma; Glioblastoma; Neurosurgical Procedures; Neoplasm Recurrence, Local; Brain Mapping
    Categories: Surgery; Genetics; Pathology; Methods; Drug Therapy; Therapy
    An extent of resection threshold for newly diagnosed glioblastomas. (2011)
    Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. (2014)

  11. Brennan, Cameron W   Neurological Surgery   Google Publications
    Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. Top Hospital
    Physician  Highly Cited  Clinical Trial  Case Reports 
    Medical school: Js Weill Medical College, Cornell University (MD, 1994)
    Medicare Accepted
    Subjects: Glioblastoma; Glioma; Neoplastic Stem Cells; ErbB Receptors; Isocitrate Dehydrogenase
    Categories: Genetics; Metabolism; Methods; Pathology; Drug Therapy; Surgery
    Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. (2010)
    The somatic genomic landscape of glioblastoma. (2013)

  12. Sloan, Andrew Edward   Neurological Surgery   Google Publications
    Department of Neurological Surgery, Seidman Cancer Center and University Hospitals of Cleveland, Case Western Reserve University, Cleveland, OH, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $3,814,957 over the last 5 years
    Medical school: Harvard Medical School (MD, 1990)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100
    Disclosed payments in 2021 from 3 biomedical companies, totalling $623.75, including $600 from  Medtronic, Inc.
    Subjects: Glioblastoma; Glioma; Neoplastic Stem Cells; Laser Therapy; Brain
    Categories: Pathology; Metabolism; Methods; Genetics; Therapy; Surgery
    The somatic genomic landscape of glioblastoma. (2013)
    Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. (2015)

  13. Mikkelsen, Tom     Google Publications
    Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan.
    Physician  Highly Cited  Highly Published  Clinical Trial  Review 
    Subjects: Glioblastoma; Glioma; Neoplasm Recurrence, Local; Antineoplastic Agents; Magnetic Resonance Imaging
    Categories: Drug Therapy; Pathology; Therapeutic Use; Genetics; Methods; Metabolism
    The somatic genomic landscape of glioblastoma. (2013)
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)

  14. Chang, Susan M   Neurological Surgery  Google Publications
    Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $2,175,899 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 62/100
    Disclosed payments from biomedical company (Servier Pharmaceuticals LLC) in 2021 for $77.43
    Subjects: Glioma; Glioblastoma; Neoplasm Recurrence, Local; Antineoplastic Agents; Magnetic Resonance Imaging
    Categories: Drug Therapy; Genetics; Methods; Pathology; Therapy; Therapeutic Use
    Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. (2010)
    Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. (2014)

  15. Sampson, John H   Neurological Surgery   ClinicalTrials.gov Google Publications
    Department of Neurosurgery, Duke University, Durham, North Carolina, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $26,501,859 over the last 5 years
    Subjects: Glioblastoma; Glioma; Cancer Vaccines; Immunotherapy; Neoplasm Recurrence, Local
    Categories: Therapy; Drug Therapy; Therapeutic Use; Immunology; Methods; Metabolism
    Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial. (2020)
    Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. (2017)

  16. Batchelor, Tracy T   Neurology   ClinicalTrials.gov Google Publications
    Department Neurology, Division of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Guideline  Clinical Trial  Case Reports  Review 
    Relevant US NIH Grant Funding: $2,280,112 over the last 5 years
    Medical school: Emory University School of Medicine (MD, 1990)
    Medicare Accepted
    Subjects: Glioblastoma; Glioma; Antineoplastic Agents; Neoplasm Recurrence, Local; Angiogenesis Inhibitors
    Categories: Drug Therapy; Therapeutic Use; Pathology; Genetics; Metabolism; Methods
    An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. (2019)
    Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)

  17. Cahill, Daniel P   Neurological Surgery   Google Publications
    Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA. Top Hospital
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Disclosed payments from biomedical company (GlaxoSmithKline, LLC.) in 2021 for $2,600
    Subjects: Glioma; Glioblastoma; Isocitrate Dehydrogenase; Mutation; Oligodendroglioma
    Categories: Genetics; Pathology; Surgery; Drug Therapy; Methods; Therapy
    Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. (2014)
    An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. (2019)

  18. Chiang, Veronica L S   Neurological Surgery   ClinicalTrials.gov Google Publications
    Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports  Review 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 68/100
    Disclosed payments in 2021 from 6 biomedical companies, totalling $7,612.15, including $7,500 from  Monteris Medical Corporation
    Subjects: Radiosurgery; Melanoma; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Laser Therapy
    Categories: Secondary; Therapy; Methods; Pathology; Surgery; Genetics
    Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. (2012)
    Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. (2016)

  19. Sulman, Erik P   Radiation Oncology   Google Publications
    YU Langone Health, New York City, NY.
    Physician  Highly Cited  Guideline  Clinical Trial  Review 
    Relevant US NIH Grant Funding: $1,932,749 over the last 5 years
    Medicare MIPS (Merit-based Incentive Payment System) rating: 86/100
    Disclosed payments from biomedical company (Novocure Inc.) in 2021 for $28.57
    Subjects: Glioblastoma; Glioma; Neoplastic Stem Cells; Biomarkers, Tumor; Mutation
    Categories: Genetics; Metabolism; Pathology; Drug Therapy; Therapeutic Use; Therapy
    A randomized trial of bevacizumab for newly diagnosed glioblastoma. (2014)
    Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (2010)

  20. Ligon, Keith L   Anatomic Pathology   Google Publications
    Broad Institute of MIT and Harvard, Cambridge.
    Physician  Highly Cited  Highly Published  Clinical Trial  Case Reports 
    Relevant US NIH Grant Funding: $668,921 over the last 5 years
    Subjects: Glioblastoma; Glioma; Astrocytoma; Mutation; Antineoplastic Agents
    Categories: Genetics; Pathology; Therapeutic Use; Drug Therapy; Methods; Metabolism
    An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. (2019)
    Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)

Note:
  1. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);